Heidi Prather
Dermatology · Austin, TXNPI 1053630582
Payments from drug & device makers
Across 779 payments — averaging $697.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$406K
- AbbVie$106K
- Merz North America, Inc.$21K
- Revance Therapeutics, Inc.$5K
- Solta Medical, A Division Of Bausch Health US, LLC$5K
- Aclaris Therapeutics, Inc.$558
- plus $613 from 11 others
Across 1 payment — averaging $76.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$76
What the payments were for
- Consulting fees$112,44021%
- Speaking & faculty fees$363,83167%
- Travel & lodging$45,3718%
- Food & beverage$21,0754%
- Education$2710%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 428 | $405,723 |
| AbbVie(2 entities) | 271 | $105,834 |
| Merz North America, Inc. | 39 | $20,746 |
| Revance Therapeutics, Inc. | 14 | $4,986 |
| Solta Medical, A Division Of Bausch Health US, LLC | 4 | $4,528 |
| Aclaris Therapeutics, Inc. | 6 | $558 |
| Amgen | 1 | $144 |
| Almirall LLC | 1 | $133 |
| Sanofi | 2 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Sun Pharmaceutical Industries Inc. | 2 | $51 |
| LEO Pharma Inc. | 2 | $45 |
| E.r. Squibb & Sons, L.L.C. | 1 | $40 |
| Novartis | 2 | $34 |
| Biofrontera Inc. | 2 | $30 |
| Incyte Corporation | 1 | $15 |
| Journey Medical Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$542,988 in reported general payments places this provider in the 95th percentile of 1,098 dermatology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 12 | $157 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Austin
- Edward LainAustin$12M
- Janet DuboisAustin$3.5M
- Daniel CarrascoAustin$1.4M
- Dale SchaeferAustin$1M
- Ali ShahbazAustin$413K
- David BushoreAustin$385K
- Blakely RichardsonAustin$279K
- Stephen TyringWebster$14.1M
- Mark LeeSan Antonio$10.9M
- John BrowningSan Antonio$10.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.